Because cancer need to perform a large amount of proliferation and migration, hyaluronic acid receptors (CD44 receptor) are expressed to an excessive degree on the cancer cell surface [17], and the drug carrier can enter the cell by endocytosis through the binding of HA and CD44 receptor. This evidence concerns the gene LYVE1 and cancer.